OneMedNet Corp(ONMD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $1.4M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ONMD Stock Analysis & AI Quality Score
AI stock analysis and institutional research for OneMedNet Corp (ONMD), a Healthcare sector company. ONMD is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $1.4m in revenue. Based on the latest XBRL financial filings (Q1 2026), OneMedNet Corp reports quarterly revenue of $96.0K, net income of $-2.5M, free cash flow of $-1.5M. Top institutional holders of ONMD by reported 13-F value include EXENCIAL WEALTH ADVISORS,, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. ONMD trades on the Nasdaq exchange and files with the SEC under CIK 1849380. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ONMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OneMedNet Corp directly from SEC EDGAR.
Revenue
Q1 2026
$96.0K
Net Income
Q1 2026
$-2.5M
Free Cash Flow
Q1 2026
$-1.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+111.4% YoYNet Income
+72.3% YoYOperating Income
-0.6% YoYEPS (Diluted)
+83.3% YoYTotal Assets
-42.3% YoYTotal Debt
-91.5% YoYOp. Cash Flow
-7.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| Revenue | $1.4M +111.4% | $643.0K -37.0% | $1.0M | — |
| Net Income | $-2.8M +72.3% | $-10.1M +70.0% | $-33.8M | — |
| Operating Income | $-9.7M -0.6% | $-9.6M -40.2% | $-6.9M | — |
| EPS (Diluted) | $-0.06 +83.3% | $-0.36 +92.3% | $-4.65 | — |
| Total Assets | $2.2M -42.3% | $3.7M +703.2% | $464.0K -99.6% | $117.9M |
| Total Debt | $1.2M -91.5% | $14.0M +1407.2% | $930.0K | — |
| Operating Cash Flow | $-7.5M -7.9% | $-7.0M -45.1% | $-4.8M | — |
AI Insight: ONMD Financial Trends
OneMedNet remains unprofitable with minimal revenue and negative equity, showing no clear path to sustainability.
• Revenue essentially flat near $0M across eight quarters; Q4 2025 spike to $1M failed to sustain in Q1 2026.
• Net income volatile between -$4M and +$3M with no consistent trend; operating income consistently negative at -$2M to -$3M.
• Total debt fell from $5M (Q2–Q1 2025) to $1M (Q4 2025–Q1 2026), but equity remains deeply negative at -$4M.
⚠ Negative equity throughout period signals balance sheet stress; equity improved from -$19M to -$4M but remains insolvent.
⚠ Operating cash flow stuck at -$2M for eight consecutive quarters despite debt reduction — underlying operations deteriorating.
AI Insight: ONMD Ratio Trends
Insufficient data: all financial ratios are missing across all periods, preventing trend analysis.
• No operational, profitability, or return metrics available for any quarter Q2 2024 through Q1 2026.
⚠ Data completeness issue must be resolved before assessing margin trends, leverage, or capital efficiency.
Get alerted when ONMD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for OneMedNet Corp including:
Top Institutional Holders of ONMD
EXENCIAL WEALTH ADVISORS, LLC
$7.1M8,377,559 shVANGUARD CAPITAL MANAGEMENT LLC
$948.2K1,115,565 shGEODE CAPITAL MANAGEMENT, LLC
$287.8K338,528 shVANGUARD FIDUCIARY TRUST CO
$116.1K136,613 shCITIGROUP INC
$115.1K135,445 shSTATE STREET CORP
$99.2K116,700 shDISCOVERY CAPITAL MANAGEMENT, LLC / CT
$95.4K112,252 shJANE STREET GROUP, LLC
$95.0K111,740 shBlackRock, Inc.
$59.6K70,096 shNORTHERN TRUST CORP
$46.7K54,944 sh
| Fund | Value | Shares |
|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | $7.1M | 8,377,559 |
| VANGUARD CAPITAL MANAGEMENT LLC | $948.2K | 1,115,565 |
| GEODE CAPITAL MANAGEMENT, LLC | $287.8K | 338,528 |
| VANGUARD FIDUCIARY TRUST CO | $116.1K | 136,613 |
| CITIGROUP INC | $115.1K | 135,445 |
| STATE STREET CORP | $99.2K | 116,700 |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $95.4K | 112,252 |
| JANE STREET GROUP, LLC | $95.0K | 111,740 |
| BlackRock, Inc. | $59.6K | 70,096 |
| NORTHERN TRUST CORP | $46.7K | 54,944 |
More Healthcare Companies
View all Healthcare →Put ONMD on your watchlist
Track score changes the day OneMedNet Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ONMD a good stock to buy?
13F Pro's AI-powered analysis of OneMedNet Corp (ONMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ONMD are available on the ONMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ONMD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ONMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OneMedNet Corp's investment landscape.